North America Lipid Market Size & Share Analysis - Growth Trends And Forecast (2026 - 2031)

The North America Lipid Market is Segmented by Product Type (Omega-3, Medium-Chain Triglycerides (MCTs), and More), by Source (Marine-Based, Plant-Based, and More), by Form (Powder, and Liquid), by Application (Functional Food and Beverages, Infant Nutrition, Pharmaceuticals, and More), and by Geography (United States, Canada, Mexico, and Rest of North America). The Market Forecasts are Provided in Terms of Value (USD).

North America Lipid Market Size and Share

Market Overview

Study Period 2021 - 2031
Base Year For Estimation2025
Forecast Data Period2026 - 2031
Market Size (2026)USD 2.74 Billion
Market Size (2031)USD 3.52 Billion
Growth Rate (2026 - 2031)5.10 % CAGR
Market ConcentrationMedium

Major Players

Major players in North America Lipid industry

*Disclaimer: Major Players sorted in no particular order.

North America Lipid Market (2025 - 2030)
Mordor Intelligence Logo
View Global Report

North America Lipid Market Analysis by Mordor Intelligence

The North American lipid market was valued at USD 2.61 billion in 2025 and estimated to grow from USD 2.74 billion in 2026 to reach USD 3.52 billion by 2031, at a CAGR of 5.10% during the forecast period (2026-2031). The market expansion is driven by increased lipid usage across various industries. Growth is supported by advancements in lipid applications, changing consumer preferences, improvements in lipid delivery systems, and supportive regulatory frameworks for health-focused product development. Consumer awareness of functional lipids' health benefits, including omega-3 fatty acids, medium-chain triglycerides (MCTs), phytosterols, and phospholipids, contributes significantly to market growth. The market is also experiencing increased adoption of plant-based and algae-derived lipid sources, aligned with sustainability initiatives and clean-label demands.

Key Report Takeaways

  • By product type, omega-3 fatty acids led with 42.75% revenue share in 2025, while medium-chain triglycerides registered the fastest 6.55% CAGR to 2031.
  • By source, plant-based inputs held 54.70% of the North America lipid market share in 2025 and are forecast to advance at 7.10% CAGR.
  • By form, liquid formats commanded 63.20% share of the North America lipid market size in 2025; powder formats are projected to rise at 7.25% CAGR.
  • By application, dietary supplements accounted for 45.20% share of the North America lipid market size in 2025; animal feed applications are expanding at 7.15% CAGR to 2031.
  • By country, the United States represented 73.10% of 2025 revenue, while Canada is set to record a 6.75% CAGR through 2031.

Segment Analysis

By Product Type: Omega-3 Dominance Faces MCT Disruption

Omega-3 fatty acids hold a 42.75% market share in 2025, maintaining their dominant position through established applications in cardiovascular health and cognitive function. Medium-chain triglycerides (MCTs) represent the fastest-growing segment with a 6.55% CAGR through 2031, driven by increasing demand in weight management and ketogenic diet applications. The omega-3 segment receives regulatory support, as the Food and Drug Administration (FDA)'s review of infant formula nutrient requirements may expand DHA and EPA requirements in early nutrition applications. Phospholipids and glycolipids find specialized uses in pharmaceutical drug delivery systems, where liposomal technology improves therapeutic efficacy through targeted delivery mechanisms.

MCTs offer distinct metabolic benefits through quick absorption and energy conversion, with clinical studies demonstrating notable weight reduction effects compared to long-chain triglycerides, especially in patients with metabolic disorders. The omega-3 segment faces supply constraints from limited marine sources. The "Others" category includes emerging lipid developments, such as structured lipids and specialty fatty acid derivatives used in industrial applications.

North America Lipid Market: Market Share by Product type, 2025

Note: Segment shares of all individual segments available upon report purchase

By Source: Plant-Based Revolution Accelerates

Plant-based sources hold a 54.70% market share in 2025 and are projected to grow at a 7.10% CAGR through 2031. This dominance stems from increasing consumer demand for sustainable and ethical lipid sources, particularly as concerns rise about the environmental impacts of marine harvesting. Marine-based sources experience sustainability challenges and supply limitations, while animal-based sources remain focused on specialized nutrition and pharmaceutical applications.

Technological advancements support this transition to plant-based alternatives. Corbion's AlgaVia platform employs microalgae cultivation with minimal resource requirements and renewable energy, providing traceable omega-3 sources for aquaculture applications. Marine sources maintain their position in premium applications requiring specific fatty acid profiles, despite supply chain instability. In agricultural innovation, Yield10 Bioscience has received USDA approval for genetically modified Camelina crops that produce 10% EPA and 10% DHA, demonstrating progress in plant-based omega-3 production.

By Form: Liquid Leadership Challenged by Powder Innovation

Liquid forms hold 63.20% market share in 2025 through established applications in food processing and direct supplementation. The powder formulations segment grows at 7.25% CAGR through 2031, supported by its stability, shelf life, and bioavailability advantages. Evonik's AvailOm omega-3 lysine complexes showcase powder innovation with 5 times higher bioavailability than traditional softgels and 4-year potency retention without additives. The powder segment offers formulation flexibility for various dosage forms and applications where liquid stability is challenging. Liquid forms remain dominant in bulk applications like food manufacturing and aquaculture feeds, where processing requirements favor liquid integration.

Nano-encapsulation technologies improve powder formulations by addressing oxidation issues and increasing bioavailability, with metal-organic framework nanoparticles showing potential for targeted delivery. The powder segment growth reflects consumer demand for convenient, stable supplementation formats that maintain potency during storage. Liquid forms maintain advantages in industrial applications requiring immediate solubility and processing compatibility, particularly in aquaculture feeds and food manufacturing. Spray-drying and microencapsulation technologies enable manufacturers to address traditional stability limitations while providing enhanced functionality in finished products.

North America Lipid Market: Market Share by Form, 2025

Note: Segment shares of all individual segments available upon report purchase

By Application: Dietary Supplements Lead While Animal Feed Surges

Dietary supplements hold a 45.20% market share in 2025, driven by increased health awareness and regulatory frameworks supporting omega-3 health claims. Animal feed applications are expected to grow at a 7.15% CAGR through 2031, primarily due to aquaculture's shift toward sustainable lipid sources. The infant nutrition segment is expanding through regulatory updates, including Health Canada's proposed revisions to foods for special dietary use, which focus on safety, nutritional adequacy, and addressing supply shortages. In pharmaceuticals, lipid-based drug delivery systems are advancing, supported by the United States government. 

The functional food and beverage segment is growing due to clean label trends and the FDA's updated "healthy" food definition that accommodates higher healthy fat content. The animal feed sector is adopting innovative approaches through algae-based omega-3 integration, exemplified by BioMar's Blue Impact feed program that combines cultivated algal oil, fish trimmings, and insect meal to decrease dependence on wild fish stocks. In infant nutrition, lipid developments focus on structured triglycerides, algae-derived DHA, and MFGM components to replicate breast milk fat composition and enhance cognitive and immune development.

Geography Analysis

The United States holds a 73.10% share of the North American lipid market in 2025, driven by pharmaceutical innovation, established dietary supplement distribution networks, and government investments in manufacturing capabilities. Lonza's USD 1.2 billion acquisition of Roche's Vacaville biologics site strengthens the country's large-scale manufacturing capacity for lipid-based therapeutics. The Food and Drug Administration (FDA)'s ongoing infant formula nutrient review process, with comments due September 2025, may expand omega-3 requirements in early nutrition products

Canada projects the highest regional growth rate at 6.75% CAGR through 2031, supported by favorable regulations and strategic marine lipid processing capabilities. Health Canada's approval of phosphatidylserine as a supplemental ingredient, with a 300 mg daily intake limit, demonstrates regulatory support for market expansion. The country's supplemented foods regulations framework balances safety and innovation through specific labeling requirements and cautionary statements.

Mexico offers developing opportunities in the North American lipid market. The Canadian Food Inspection Agency outlines export requirements for meat and poultry products to Mexico, including various by-products containing lipid components, with emphasis on proper labeling and documentation. The Rest of North America comprises smaller markets with distinct regulatory environments and specialized applications, though market analysis remains limited due to data constraints.

Reports are available across multiple geographies - Mordor Intelligence

Reports are available across multiple geographies.

Gain in-depth market insights across regions to support informed decisions.

Competitive Landscape

Market Concentration

Cargill Incorporated, Koninklijke DSM N.V., BASF SE, Omega Protein Corporation, Kerry Group plc

The North America lipid market demonstrates a moderate level of fragmentation. This market structure facilitates strategic consolidation opportunities while fostering competitive dynamics that enhance innovation and maintain pricing efficiency. The market's competitive environment is dominated by established organizations, including Cargill Incorporated, BASF SE, Kerry Group plc, Croda International Plc, and Bunge Ltd, each contributing significantly to market development and technological advancement.

Market leaders are implementing comprehensive vertical integration strategies to strengthen their competitive positions. A notable example is KD Pharma's strategic acquisition of DSM-Firmenich's marine lipids business in October 2024, which included the MEG-3 brand and production facilities in Canada and Peru. This acquisition exemplifies the industry trend toward consolidation and technological advancement in pharmaceutical and dietary supplement applications.

The competitive landscape presents significant opportunities in sustainable production technologies and pharmaceutical applications, with emerging companies introducing innovative production methods to gain market share. Regulatory compliance requirements serve as a critical differentiator among market participants, while established companies such as Archer Daniels Midland maintain their market positions through robust governance frameworks and operational transparency in their Nutrition segment. This competitive environment encourages continuous innovation and operational excellence among market participants.

North America Lipid Industry Leaders

Dots and Lines - Pattern
1 Cargill Incorporated
2 BASF SE
3 Kerry Group plc
4 Croda International Plc
5 Bunge Ltd.

*Disclaimer: Major Players sorted in no particular order

Mordor Intelligence Logo

Recent Industry Developments

  • March 2025: Croda International Plc opened a new lipids manufacturing facility in Lamar, Pennsylvania, United States. The 23,680 square foot, multi-purpose facility strengthens Croda's production capabilities for drug delivery system components, including lipids.
  • October 2024: Ahlstrom Corporation introduced Lipid Saver, a specialized solution developed for the collection, transportation, and storage of fatty acids derived from whole blood samples.
  • December 2023: Lipoid introduced a new product quality for LIPOID PE 18:1 that enables quick and complete dissolution in ethanol, simplifying customer processing operations. This enhancement aligns with the company's continuous improvement of production processes and product offerings.
  • March 2023: Evonik opened a new GMP facility to manufacture lipids for advanced pharmaceutical drug delivery applications. The lipid launch facility, located at the company's site in Hanau, Germany, provides customers with lipid quantities needed for clinical and small-scale commercial manufacturing.

Table of Contents for North America Lipid Industry Report

1. INTRODUCTION

  • 1.1Study Assumptions and Market Definition
  • 1.2Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET LANDSCAPE

  • 4.1Market Overview
  • 4.2Market Drivers
    • 4.2.1Rising popularity of fortified functional foods and beverages
    • 4.2.2Expanding adoption of omega-3 and functional lipids in dietary supplements and nutraceuticals
    • 4.2.3Widening use of MCTs (medium-chain triglycerides) in weight management diets
    • 4.2.4Growing demand for plant-based and algae-derived lipids
    • 4.2.5Pharmaceutical innovation using lipids in drug delivery systems
    • 4.2.6Increasing investment in algae-based lipid production technologies
  • 4.3Market Restraints
    • 4.3.1Volatility in raw material prices
    • 4.3.2Stringent purity and safety regulations
    • 4.3.3Negative consumer perception of highly processed lipids
    • 4.3.4Limited algal fermentation infrastructure
  • 4.4Supply Chain Analysis
  • 4.5Regulatory Outlook
  • 4.6Porter’s Five Forces
    • 4.6.1Threat of New Entrants
    • 4.6.2Bargaining Power of Buyers/Consumers
    • 4.6.3Bargaining Power of Suppliers
    • 4.6.4Threat of Substitute Products
    • 4.6.5Intensity of Competitive Rivalry

5. MARKET SIZE AND GROWTH FORECASTS (VALUE)

  • 5.1By Product Type
    • 5.1.1Omega-3
    • 5.1.2Medium-Chain Triglycerides (MCTs)
    • 5.1.3Phospholipids and Glycolipids
    • 5.1.4Others
  • 5.2By Source
    • 5.2.1Marine-based
    • 5.2.2Plant-based
    • 5.2.3Animal-based
  • 5.3By Form
    • 5.3.1Powder
    • 5.3.2Liquid
  • 5.4By Application
    • 5.4.1Functional Food and Beverages
    • 5.4.2Infant Nutrition
    • 5.4.3Pharmaceuticals
    • 5.4.4Dietary Supplements
    • 5.4.5Animal Feed
    • 5.4.6Others
  • 5.5By Country
    • 5.5.1United States
    • 5.5.2Canada
    • 5.5.3Mexico
    • 5.5.4Rest of North America

6. COMPETITIVE LANDSCAPE

  • 6.1Market Concentration
  • 6.2Strategic Moves
  • 6.3Market Ranking Analysis
  • 6.4Company Profiles (includes Global-level Overview, Market-level Overview, Core Segments, Financials (if available), Strategic Information, Market Rank/Share, Products and Services, Recent Developments)
    • 6.4.1Cargill Incorporated
    • 6.4.2BASF SE
    • 6.4.3Kerry Group plc
    • 6.4.4Croda International Plc
    • 6.4.5Bunge Ltd.
    • 6.4.6KD Pharma Group SA
    • 6.4.7Merck KGaA
    • 6.4.8Solutex GC, S.L.
    • 6.4.9Epax Norway AS
    • 6.4.10GC Rieber Oils AS
    • 6.4.11Archer Daniels Midland Company
    • 6.4.12Golden Omega S.A.
    • 6.4.13Omega Protein Corporation
    • 6.4.14Plant Lipids Pvt Ltd
    • 6.4.15Aker BioMarine ASA
    • 6.4.16Lonza Group Ltd.
    • 6.4.17Nissui Corporation
    • 6.4.18Associated British Foods
    • 6.4.19Lonza Group
    • 6.4.20Stepan Company

7. MARKET OPPORTUNITIES AND FUTURE OUTLOOK

North America Lipid Market Report Scope

North American Lipid Market is segmented by product type, application, and geography. On the basis of product type, the market is segmented into omega 3 and omega 6, medium-chain triglycerides (MCTs), and other product types. On the basis of application, the market is segmented into functional food and beverages, infant nutrition, pharmaceuticals, dietary supplements, animal feed, and pet food, and cosmetics., Based on geography, the report provide a regional analysis, which includes United States, Mexico, Canada, and rest of North America.

Key Questions Answered in the Report

What is the current value of the North America lipid market?
It stands at USD 2.74 billion in 2026 and is projected to reach USD 3.52 billion by 2031.
Which segment holds the largest North America lipid market share?
Omega-3 fatty acids remain dominant, accounting for 42.75% of 2025 revenue.
Why are MCTs gaining popularity in North America?
Clinical evidence shows MCTs enhance fat oxidation and energy metabolism, supporting weight-management and ketogenic diets, which drives a 6.55% CAGR.
How are regulations influencing lipid-fortified foods?
The FDA’s February 2025 “healthy” rule permits higher unsaturated fats, encouraging broader use of functional lipids in food formulations.
Page last updated on:
Latest Case Studies
  • Food & Beverage
    2nd May

    Market Analysis of Synthetic Food Colorants for a Beverage Leader


    5 Min Read

  • Food & Beverage
    29th July

    Unlocking Growth in Frozen-Cooked Ready Meals


    4 Min Read

  • Manufacturing Products and Services
    22nd May

    US Market Entry for Taiwanese Machine Tool Manufacturers


    5 Min Read

Dots and Lines - Pattern
CONTACT US

When decisions matter, industry leaders turn to our analysts. Let’s talk.

🌐Country code
down